Generation	O
and	O
analyses	B:C0936012
of	O
human	O
synthetic	O
antibody	I:C0598139
libraries	I:C0598139
and	O
their	O
application	O
for	O
protein	O
microarrays	O
Antibody	O
-	O
based	O
proteomics	O
offers	O
distinct	O
advantages	O
in	O
the	O
analysis	O
of	O
complex	O
samples	O
for	O
discovery	O
and	O
validation	O
of	O
biomarkers	O
associated	O
with	O
disease	O
.	O

Generation	O
and	O
analyses	O
of	O
human	B:C0086418
synthetic	O
antibody	I:C0598139
libraries	I:C0598139
and	O
their	O
application	O
for	O
protein	O
microarrays	O
Antibody	O
-	O
based	O
proteomics	O
offers	O
distinct	O
advantages	O
in	O
the	O
analysis	O
of	O
complex	O
samples	O
for	O
discovery	O
and	O
validation	O
of	O
biomarkers	O
associated	O
with	O
disease	O
.	O

Generation	O
and	O
analyses	O
of	O
human	O
synthetic	B:C0598139
antibody	I:C0598139
libraries	I:C0598139
and	O
their	O
application	O
for	O
protein	O
microarrays	O
Antibody	O
-	O
based	O
proteomics	O
offers	O
distinct	O
advantages	O
in	O
the	O
analysis	O
of	O
complex	O
samples	O
for	O
discovery	O
and	O
validation	O
of	O
biomarkers	O
associated	O
with	O
disease	O
.	O

Generation	O
and	O
analyses	O
of	O
human	O
synthetic	O
antibody	I:C0598139
libraries	I:C0598139
and	O
their	O
application	O
for	O
protein	O
microarrays	O
Antibody	B:C0003241
-	O
based	O
proteomics	O
offers	O
distinct	O
advantages	O
in	O
the	O
analysis	O
of	O
complex	O
samples	O
for	O
discovery	O
and	O
validation	O
of	O
biomarkers	O
associated	O
with	O
disease	O
.	O

Generation	O
and	O
analyses	O
of	O
human	O
synthetic	O
antibody	I:C0598139
libraries	I:C0598139
and	O
their	O
application	O
for	O
protein	O
microarrays	O
Antibody	O
-	O
based	O
proteomics	B:C0872252
offers	O
distinct	O
advantages	O
in	O
the	O
analysis	O
of	O
complex	O
samples	O
for	O
discovery	O
and	O
validation	O
of	O
biomarkers	O
associated	O
with	O
disease	O
.	O

Generation	O
and	O
analyses	O
of	O
human	O
synthetic	O
antibody	I:C0598139
libraries	I:C0598139
and	O
their	O
application	O
for	O
protein	O
microarrays	O
Antibody	O
-	O
based	O
proteomics	O
offers	O
distinct	O
advantages	O
in	O
the	O
analysis	B:C0936012
of	O
complex	O
samples	O
for	O
discovery	O
and	O
validation	O
of	O
biomarkers	O
associated	O
with	O
disease	O
.	O

Generation	O
and	O
analyses	O
of	O
human	O
synthetic	O
antibody	I:C0598139
libraries	I:C0598139
and	O
their	O
application	O
for	O
protein	O
microarrays	O
Antibody	O
-	O
based	O
proteomics	O
offers	O
distinct	O
advantages	O
in	O
the	O
analysis	O
of	O
complex	O
samples	O
for	O
discovery	O
and	O
validation	B:C1519941
of	O
biomarkers	O
associated	O
with	O
disease	O
.	O

Generation	O
and	O
analyses	O
of	O
human	O
synthetic	O
antibody	I:C0598139
libraries	I:C0598139
and	O
their	O
application	O
for	O
protein	O
microarrays	O
Antibody	O
-	O
based	O
proteomics	O
offers	O
distinct	O
advantages	O
in	O
the	O
analysis	O
of	O
complex	O
samples	O
for	O
discovery	O
and	O
validation	O
of	O
biomarkers	B:C0005516
associated	O
with	O
disease	O
.	O

Generation	O
and	O
analyses	O
of	O
human	O
synthetic	O
antibody	I:C0598139
libraries	I:C0598139
and	O
their	O
application	O
for	O
protein	O
microarrays	O
Antibody	O
-	O
based	O
proteomics	O
offers	O
distinct	O
advantages	O
in	O
the	O
analysis	O
of	O
complex	O
samples	O
for	O
discovery	O
and	O
validation	O
of	O
biomarkers	O
associated	O
with	O
disease	B:C0012634
.	O

However	O
,	O
its	O
large	O
-	O
scale	O
implementation	O
requires	O
tools	O
and	O
technologies	B:C1513384
that	O
allow	O
development	O
of	O
suitable	O
antibody	O
or	O
antibody	O
fragments	I:C0003241
in	O
a	O
high	O
-	O
throughput	O
manner	O
.	O

However	O
,	O
its	O
large	O
-	O
scale	O
implementation	O
requires	O
tools	O
and	O
technologies	O
that	O
allow	O
development	O
of	O
suitable	O
antibody	B:C0003241
or	O
antibody	O
fragments	I:C0003241
in	O
a	O
high	O
-	O
throughput	O
manner	O
.	O

However	O
,	O
its	O
large	O
-	O
scale	O
implementation	O
requires	O
tools	O
and	O
technologies	O
that	O
allow	O
development	O
of	O
suitable	O
antibody	O
or	O
antibody	B:C0003241
fragments	I:C0003241
in	O
a	O
high	O
-	O
throughput	O
manner	O
.	O

To	O
address	O
this	O
we	O
designed	O
and	O
constructed	O
two	O
human	B:C0086418
synthetic	O
antibody	I:C0598139
fragment	I:C0598139
(	I:C0598139
scFv	I:C0598139
)	I:C0598139
libraries	I:C0598139
denoted	O
HelL	O
-	I:C0003241
11	I:C0003241
and	O
HelL	O
-	I:C0003241
13	I:C0003241
.	O

To	O
address	O
this	O
we	O
designed	O
and	O
constructed	O
two	O
human	O
synthetic	B:C0598139
antibody	I:C0598139
fragment	I:C0598139
(	I:C0598139
scFv	I:C0598139
)	I:C0598139
libraries	I:C0598139
denoted	O
HelL	O
-	I:C0003241
11	I:C0003241
and	O
HelL	O
-	I:C0003241
13	I:C0003241
.	O

To	O
address	O
this	O
we	O
designed	O
and	O
constructed	O
two	O
human	O
synthetic	O
antibody	I:C0598139
fragment	I:C0598139
(	I:C0598139
scFv	I:C0598139
)	I:C0598139
libraries	I:C0598139
denoted	O
HelL	B:C0003241
-	I:C0003241
11	I:C0003241
and	O
HelL	O
-	I:C0003241
13	I:C0003241
.	O

To	O
address	O
this	O
we	O
designed	O
and	O
constructed	O
two	O
human	O
synthetic	O
antibody	I:C0598139
fragment	I:C0598139
(	I:C0598139
scFv	I:C0598139
)	I:C0598139
libraries	I:C0598139
denoted	O
HelL	O
-	I:C0003241
11	I:C0003241
and	O
HelL	B:C0003241
-	I:C0003241
13	I:C0003241
.	O

By	O
the	O
use	O
of	O
phage	B:C3494191
display	I:C3494191
technology	I:C3494191
,	O
in	O
total	O
466	O
unique	O
scFv	O
antibodies	I:C0003241
specific	O
for	O
114	O
different	O
antigens	O
were	O
generated	O
.	O

By	O
the	O
use	O
of	O
phage	O
display	I:C3494191
technology	I:C3494191
,	O
in	O
total	O
466	O
unique	O
scFv	B:C0003241
antibodies	I:C0003241
specific	O
for	O
114	O
different	O
antigens	O
were	O
generated	O
.	O

By	O
the	O
use	O
of	O
phage	O
display	I:C3494191
technology	I:C3494191
,	O
in	O
total	O
466	O
unique	O
scFv	O
antibodies	I:C0003241
specific	O
for	O
114	O
different	O
antigens	B:C0003320
were	O
generated	O
.	O

The	O
specificities	O
of	O
these	O
antibodies	B:C0003241
were	O
analyzed	O
in	O
a	O
variety	O
of	O
immunochemical	O
assays	I:C0519671
and	O
a	O
subset	O
was	O
further	O
evaluated	O
for	O
functionality	O
in	O
protein	O
microarray	O
applications	O
.	O

The	O
specificities	O
of	O
these	O
antibodies	O
were	O
analyzed	O
in	O
a	O
variety	O
of	O
immunochemical	B:C0519671
assays	I:C0519671
and	O
a	O
subset	O
was	O
further	O
evaluated	O
for	O
functionality	O
in	O
protein	O
microarray	O
applications	O
.	O

This	O
high	O
-	O
throughput	O
approach	O
demonstrates	O
the	O
ability	O
to	O
rapidly	O
generate	O
a	O
wealth	O
of	O
reagents	B:C0034760
not	O
only	O
for	O
proteome	O
research	O
,	O
but	O
potentially	O
also	O
for	O
diagnostics	O
and	O
therapeutics	O
.	O

This	O
high	O
-	O
throughput	O
approach	O
demonstrates	O
the	O
ability	O
to	O
rapidly	O
generate	O
a	O
wealth	O
of	O
reagents	O
not	O
only	O
for	O
proteome	B:C0751973
research	O
,	O
but	O
potentially	O
also	O
for	O
diagnostics	O
and	O
therapeutics	O
.	O

This	O
high	O
-	O
throughput	O
approach	O
demonstrates	O
the	O
ability	O
to	O
rapidly	O
generate	O
a	O
wealth	O
of	O
reagents	O
not	O
only	O
for	O
proteome	O
research	B:C0035168
,	O
but	O
potentially	O
also	O
for	O
diagnostics	O
and	O
therapeutics	O
.	O

This	O
high	O
-	O
throughput	O
approach	O
demonstrates	O
the	O
ability	O
to	O
rapidly	O
generate	O
a	O
wealth	O
of	O
reagents	O
not	O
only	O
for	O
proteome	O
research	O
,	O
but	O
potentially	O
also	O
for	O
diagnostics	B:C1511890
and	O
therapeutics	O
.	O

This	O
high	O
-	O
throughput	O
approach	O
demonstrates	O
the	O
ability	O
to	O
rapidly	O
generate	O
a	O
wealth	O
of	O
reagents	O
not	O
only	O
for	O
proteome	O
research	O
,	O
but	O
potentially	O
also	O
for	O
diagnostics	O
and	O
therapeutics	B:C0087111
.	O

In	O
addition	O
,	O
this	O
work	O
provides	O
a	O
great	O
example	O
on	O
how	O
a	O
synthetic	O
approach	O
can	O
be	O
used	O
to	O
optimize	O
library	B:C0598139
designs	I:C0598139
.	O

By	O
having	O
precise	O
control	O
of	O
the	O
diversity	O
introduced	O
into	O
the	O
antigen	B:C0003320
-	O
binding	O
sites	I:C0005456
,	O
synthetic	O
libraries	I:C0598139
offer	O
increased	O
understanding	O
of	O
how	O
different	O
diversity	O
contributes	O
to	O
antibody	O
binding	O
reactivity	O
and	O
stability	O
,	O
thereby	O
providing	O
the	O
key	O
to	O
future	O
library	O
optimization	O
.	O

By	O
having	O
precise	O
control	O
of	O
the	O
diversity	O
introduced	O
into	O
the	O
antigen	O
-	O
binding	B:C0005456
sites	I:C0005456
,	O
synthetic	O
libraries	I:C0598139
offer	O
increased	O
understanding	O
of	O
how	O
different	O
diversity	O
contributes	O
to	O
antibody	O
binding	O
reactivity	O
and	O
stability	O
,	O
thereby	O
providing	O
the	O
key	O
to	O
future	O
library	O
optimization	O
.	O

By	O
having	O
precise	O
control	O
of	O
the	O
diversity	O
introduced	O
into	O
the	O
antigen	O
-	O
binding	O
sites	I:C0005456
,	O
synthetic	B:C0598139
libraries	I:C0598139
offer	O
increased	O
understanding	O
of	O
how	O
different	O
diversity	O
contributes	O
to	O
antibody	O
binding	O
reactivity	O
and	O
stability	O
,	O
thereby	O
providing	O
the	O
key	O
to	O
future	O
library	O
optimization	O
.	O

By	O
having	O
precise	O
control	O
of	O
the	O
diversity	O
introduced	O
into	O
the	O
antigen	O
-	O
binding	O
sites	I:C0005456
,	O
synthetic	O
libraries	I:C0598139
offer	O
increased	O
understanding	O
of	O
how	O
different	O
diversity	O
contributes	O
to	O
antibody	B:C0003241
binding	O
reactivity	O
and	O
stability	O
,	O
thereby	O
providing	O
the	O
key	O
to	O
future	O
library	O
optimization	O
.	O

By	O
having	O
precise	O
control	O
of	O
the	O
diversity	O
introduced	O
into	O
the	O
antigen	O
-	O
binding	O
sites	I:C0005456
,	O
synthetic	O
libraries	I:C0598139
offer	O
increased	O
understanding	O
of	O
how	O
different	O
diversity	O
contributes	O
to	O
antibody	O
binding	O
reactivity	O
and	O
stability	O
,	O
thereby	O
providing	O
the	O
key	O
to	O
future	O
library	B:C0598139
optimization	O
.	O

